Molecules/YTTRIUM Y 90 IBRITUMOMAB TIUXETAN

YTTRIUM Y 90 IBRITUMOMAB TIUXETAN

CHEMBL2108667

Compare

Molecular Identity

YTTRIUM Y 90 IBRITUMOMAB TIUXETAN

ChEMBL ID: CHEMBL2108667

AntibodyApprovedFirst approved 2002

Mechanism of action: B-lymphocyte antigen CD20 binding agent

Properties

Molecular Formula

0.00

Molecular Weight

g/mol

Synonyms(9)

90Y-IBRITUMOMAB(90)Y-IBRITUMOMAB TIUXETAN90Y IBRITUMOMAB TIUXETANIBRITUMOMAB TIUXETAN Y-90IBRITUMOMAB TIUXETAN YTTRIUM Y-90YTTRIUM (90Y) IBRITUMOMAB TIUXETANYTTRIUM Y 90 IBRITUMOMAB TIUXETANYTTRIUM Y-90 IBRITUMOMAB TIUXETANZEVALIN

Data from ChEMBL (EMBL-EBI)

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Drug Network

Trials and conditions connected to YTTRIUM Y 90 IBRITUMOMAB TIUXETAN

Loading drug network...